Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
03/2005
03/30/2005CN1602360A Methods of increasing endogenous erythropoietin (EPO)
03/30/2005CN1602317A Angiopoietin-2 specific binding agents
03/30/2005CN1602311A Use of 2-amino-4-pyridylmethyl-thiazoline derivatives as inhibitors of inducible NO-synthase
03/30/2005CN1602310A Benzothiazoles compound
03/30/2005CN1602307A Substituted 6h-dibenzo[c, h]chromenes as estrogenic agents
03/30/2005CN1602199A Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation
03/30/2005CN1602196A Ureas of 2-aminobenzothiazoles as adenosine modulators
03/30/2005CN1602187A Valdecoxib-based composition prepared by spray drying process and exhibiting rapid oral dissolution
03/30/2005CN1600791A SARS antigen peptide
03/30/2005CN1600363A Recipe of Chinese traditional medicine for treating gorge disease
03/30/2005CN1600356A Combination of Chinese traditional medicine for curing chronic pharyngitis and preparation method
03/30/2005CN1600354A Granule of compound eupatorium
03/30/2005CN1600348A Honey for relieving a cough and preparation method
03/30/2005CN1600344A Nasal bleeding pellet
03/30/2005CN1600329A Application of 'Kudiezi' injection in use for preparing antiviral remedy
03/30/2005CN1600328A Prepared Chinese medicine for treating pneumonia
03/30/2005CN1600313A Cefetamet pivoxil hydrochloride dispersion dispersion tablets and preparation method
03/30/2005CN1600308A Application of l-sophocarpine on preparing medication for curing disease caused by coronavirus
03/30/2005CN1600304A Application of extractive of ussurian grape on curing inflammatory disease
03/30/2005CN1194976C Thienodibenzoazulene compounds as tumor necrosis factor inhibitors
03/30/2005CN1194752C Anti-virus Chinese medicine composition and preparation process thereof
03/30/2005CN1194739C Medicine composition for treating cold and cough, and its prepn. method
03/30/2005CN1194738C Medical ointment for treating child cough with dyspnea and its preparation method
03/30/2005CN1194707C Use of lactobacillus casei in immunostimulatory peptides
03/30/2005CN1194700C Globeflower powder for injection and its prepn
03/30/2005CN1194690C Composition for treating bronchial asthma and allergic rhinitis
03/29/2005US6872746 Isomeric fused pyrrolocarbazoles and isoindolones
03/29/2005US6872743 Antiinflammatory agents; sepsis shock; antiarthritic agents
03/29/2005US6872738 Product comprising at least a no synthase inhibiting substance associated with at least a phospholipase a2 inhibiting substance
03/29/2005US6872735 LFA-1 antagonist compounds
03/29/2005US6872733 Benzimidazolone compounds
03/29/2005US6872721 Derivatives of 2,3,6,7,12,12a-hexahydropyrazino-[1′,2′:1,6]pyrido[3,4b]-indole-1,4-dione
03/29/2005US6872719 Antiinflammatory agents; autoimmune disease
03/29/2005CA2335186C Pyrrolo[2,3-d]pyrimidine compounds
03/29/2005CA2261760C Sulfonamides and derivatives thereof that modulate the activity of endothelin
03/29/2005CA2217169C Thienyl-, furyl-, pyrrolyl- and biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
03/24/2005WO2005026173A1 Substituted thienoimidazoles, method for production and use thereof as medicament or diagnostic and medicaments comprising the same
03/24/2005WO2005026138A1 2-naphthylimino-1,3-thiazine derivative
03/24/2005WO2005026132A1 cAMP-SPECIFIC PHOSPHODIESTERASE INHIBITOR
03/24/2005WO2005026095A1 Process for the preparation of roflumilast
03/24/2005WO2005025621A1 Methods and compositions for reducing the risk associated with the administration of opioid analgesics in patients with diagnosed or undiagnosed respiratory illness
03/24/2005WO2005025608A1 Ifn-ϝ for treatment of diseases associated with malfunction of the nod2 gene
03/24/2005WO2005025578A1 Use of ciclesonide for the treatment of respiratory diseases
03/24/2005WO2005025540A2 Mucoactive agents for treating a pulmonary disease
03/24/2005WO2004110379A3 A1 adenosine receptor antagonists
03/24/2005WO2004078756A3 Jnk inhibitors
03/24/2005WO2004073619A3 Ccr8 antagonists
03/24/2005WO2004017948A8 Use of lck inhibitor for treatment of immunologic diseases
03/24/2005WO2002092759A9 Molecules for disease detection and treatment
03/24/2005US20050065341 Substituted 8-heteroaryl xanthines
03/24/2005US20050065327 Immunoglobulin specific to interleukin-13 (IL-13) for use in prevention and treatment of asthma, fibrosis, skin and cell proliferative disorders
03/24/2005US20050065211 Ester derivatives
03/24/2005US20050065195 Oxadiazolyl-biphenylcarboxamides and their use as p38 kinase inhibitors
03/24/2005US20050065153 Antiinflamamtory agents; respiratory system disorders; autoimmune disease
03/24/2005US20050065110 Synergistic mixture; antioxidant; cardiovascular disorders; antidiabetic agents
03/24/2005US20050065093 Inhibitors of the ICE/ced-3 family of cysteine proteases
03/24/2005US20050064491 Transport protein for use as tool in identifying modulator for treatment of sleep, nervous suystem, anixety, eating, cardiovascular and pain disordere
03/24/2005US20050064458 Nucleotide sequences coding membrane protein for use in diagnosis, prevention and treatnment of cell proliferative, nervous system, metabolic and inflammatory disorders
03/24/2005US20050064404 Regulation of human serotonin-like g protein-coupled receptor
03/24/2005US20050064014 Use of cystathionine
03/24/2005US20050063977 Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (SCLC)
03/24/2005US20050063943 Conjugated of hydroxyalkyl starch and an active agent
03/24/2005US20050063911 Accurate metered single inhalation administration
03/24/2005US20050063910 Medicaments for asthma treatment
03/24/2005CA2538399A1 Pharmaceutical compostions
03/24/2005CA2537695A1 Substituted thienoimidazoles, method for production and use thereof as medicament or diagnostic and medicaments comprising the same
03/23/2005EP1517144A2 Method of identifying an antibody binding to and modulating the activity of a human vanilloid receptor
03/23/2005EP1516639A1 Device in the treatment of pulmonary vasoconstriction and asthma
03/23/2005EP1516627A1 Interferon-Gamma for the treatment of diseases associated with the NOD2 gene
03/23/2005EP1516064A2 Methods of using 46828, a human acyl-coa synthetase
03/23/2005EP1515975A1 Benzofused heteroaryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use
03/23/2005EP1515968A2 Quinuclidine derivatives and pharmaceutical compositions containing the same
03/23/2005EP1515964A1 Substituted diaminopyrimidines
03/23/2005EP1515942A1 Carboxamides derivatives
03/23/2005EP1515753A1 Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation
03/23/2005EP1515745A1 Use of compounds having the biological activity of vasoactive intestinal peptide for the treatment of sarcoidosis
03/23/2005EP1515743A2 Use of osteoprotegerin for the prevention and/or treatment of fibrosis/sclerosis
03/23/2005EP1515731A1 Anti-spasmodic comprising xenon
03/23/2005EP1515727A2 (halo-benzo carbonyl)heterobicyclic p38 kinase inhibiting agents
03/23/2005EP1515719A2 Enhancing treatment of mdr cancer with adenosine a3 antagonists
03/23/2005EP1515713A1 Pharmaceutical compositions for the treatment of infections of the respiratory system by pathogenic agents
03/23/2005EP1335728B1 Medicament compositions based on tiotropium salts and on salmeterol salts
03/23/2005EP1089733B1 Use of optically pure (+)-norcisapride for treating irritable bowel syndrome
03/23/2005CN1599745A Crystalline form of a ribofuranosyluronamide derivative; a human adenosine a2a receptor agonist
03/23/2005CN1599741A Thioether substituted imidazoquinolines
03/23/2005CN1599740A Amide substituted imidazopyridines
03/23/2005CN1599739A Sulfonamido substituted imidazopyridines
03/23/2005CN1599738A Urea substituted imidazopyridines
03/23/2005CN1599737A Ring fused pyrazole derivatives
03/23/2005CN1599734A 3, 4-di-substituted maleimide compounds as CXC-chemokine receptor antagonists
03/23/2005CN1599733A N-ureido-piperidines as antagonists viii for CCR-3 receptor
03/23/2005CN1599724A Imidazole-4-carboxamide derivatives, preparation and use thereof for treatment of obesity
03/23/2005CN1599722A 4-piperidinyl alkylamine derivatives as muscarinic receptor antagonists
03/23/2005CN1599721A CCR-3 receptor antagonists VII
03/23/2005CN1599717A Cyclic diamine compounds having fused-ring groups
03/23/2005CN1599625A Use of an h1 antagonist and a safe steroid to treat rhinitis
03/23/2005CN1599618A Stabilization of hypoxia inducible factor (HIF) alpha
03/23/2005CN1599613A Combinations for the treatment of immunoinflammatory disorders
03/23/2005CN1599611A Piperazine derivatives for use as CCR-3 receptor antagonists in the treatment of asthma
03/23/2005CN1599610A Preparation of pharmaceutical salts of 4((z)-(4-bromophenyl)(ethoxyimino)methyl)-1'-((2, 4-dimethyl-1-oxido-3-pyridinyl)carbonyl)-4'-methyl-1, 4'bipiperidine as ccr5-antagonists for the treatment of aid
1 ... 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 ... 878